skip to main content

The Science to Prevail

We are developing disease-modifying gene therapies for patients with Parkinson’s disease and other neurodegenerative disorders.

learn more

verb \ pre·vail \ pre-‘vāl

To prove more powerful than opposing forces. To be victorious. To gain ascendance through strength. To triumph. We are developing disease-modifying gene therapies to prevail against neurodegenerative diseases.

Prevail Therapeutics is applying precision medicine to the development of gene therapies to slow or stop disease progression in patients with Parkinson’s disease and other neurodegenerative disorders.

We are leveraging recent breakthroughs in human genetics and the transformative success of AAV-based gene therapy to achieve this goal.

learn more

Moving To Cure

We are building a team dedicated to dramatically improving treatment outcomes for patients with neurodegenerative diseases. Learn more about career opportunities at Prevail.

join our team

Prevail Therapeutics featured on “Behind the Mystery”, a recurring series by The Balancing Act that is devoted to advocating for rare and genetic diseases alongside patients and their advocates.

The ground-breaking episode, “Behind the Mystery of Gaucher Disease”, made its debut on October 2, 2023 on Lifetime TV. It covers important topics ranging from exploring current treatment options, such as enzyme replacement and oral therapies, to the future of research, including gene transfer therapies that could reduce the need for frequent interventions to improve quality of life.

learn more & watch the episode

You are now leaving prevailtherapeutics.com

You've clicked on a link for a third-party site, which Prevail Therapeutics does not control, influence, or endorse. Prevail is not responsible for any content on this third-party site, including the privacy policy. Click "Continue" to leave or "Go Back" to return to prevailtherapeutics.com

Top